|
Re: Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine
|
5
|
Resverlogix Corp.
|
Mar 18, 2022 10:33AM
|
|
Re: CityNews cover
|
5
|
Resverlogix Corp.
|
Jan 31, 2022 02:29PM
|
|
Re: To our scientist
|
5
|
Resverlogix Corp.
|
Dec 05, 2020 10:03AM
|
|
Re: Hello
|
5
|
Resverlogix Corp.
|
Feb 16, 2022 03:41PM
|
|
Re: Apropos AGM
|
5
|
Resverlogix Corp.
|
Jun 08, 2022 06:49PM
|
|
Re: I would rather,...
|
5
|
Resverlogix Corp.
|
Dec 07, 2019 10:11AM
|
|
Re: Come on RVX ... ONE TIME
|
5
|
Resverlogix Corp.
|
Oct 09, 2019 10:36AM
|
|
Re: Resverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular Dystrophy
|
5
|
Resverlogix Corp.
|
Oct 04, 2023 09:03AM
|
|
Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
5
|
Resverlogix Corp.
|
Dec 13, 2021 06:12AM
|
|
Re: got this & sent a response/follow up minutes before …
|
5
|
Zenith Epigenetics
|
Dec 12, 2023 01:52PM
|
|
Re: Trading
|
5
|
Zenith Epigenetics
|
Sep 22, 2022 03:16PM
|
|
Re: New Variant
|
5
|
Resverlogix Corp.
|
Nov 27, 2021 03:22PM
|
|
Re: Management Information Circular
|
5
|
Resverlogix Corp.
|
Jul 12, 2024 08:34AM
|
|
The Non-Brokered Offering
|
5
|
Resverlogix Corp.
|
Jun 05, 2019 08:54AM
|
|
Re: I am hoping...
|
5
|
Resverlogix Corp.
|
Oct 09, 2019 12:18PM
|
|
Re: Filings not doing much for trading....Here's a thought
|
5
|
Resverlogix Corp.
|
Dec 14, 2018 02:10PM
|
|
Re: So I was able to finally set up a one on one meeting with...
|
5
|
Resverlogix Corp.
|
Mar 14, 2022 06:05AM
|
|
Re: This weekends conference
|
5
|
Resverlogix Corp.
|
Aug 30, 2019 03:56PM
|
|
Financial Reporting Dec 31, 2021 + MD&A now on SEDAR
|
5
|
Resverlogix Corp.
|
Apr 01, 2022 05:47AM
|
|
Re: New MD&A posted
|
5
|
Resverlogix Corp.
|
Dec 17, 2019 11:02AM
|
